Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Biogen	BIIB	Healthcare \| Drug Manufacturers - General	90	13.2%

Current Price (01/27)			$218.94
CAPS Rating (Rate this stock on CAPS)

Expected Income Statement
Current Sales			11,100.5
Sales Growth Forecast			10.5%
Net Profit Margin			26.3%

Projected Shares Outstanding			130.02
EPS - Five year Forecast			$36.99
Average P/E Ratio			11.0
Projected Average Price			$406.88

Price Appreciation (Annualized)			13.2%
Annual Dividend Yield			0.0%
Projected Annual Return			13.2%

Quality
Financial Strength			90	22.5
EPS Stability			76	19.1
Industry Sales Growth Rate			8.0%	16.4
Industry Net Profit Margin			22.5%	14.6
Calculated Quality Rating			72.6

Fool CAPS
Total Players 963 Outperforms 77 Underperforms All-Stars (212) 196 Outperforms (92%) 16 Underperforms

Fundamental Data Updated: 12/31/2021

MIPAR	9.6%
Sweet Spot	14.6% - 19.6%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow	PAR is above the target range of MIPAR +10%, currently 10.1%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.